Randomized Clinical Trial by Conglomerates on the Efficacy of Maintenance of Physical Exercise in Myocardial Ischemia
CarPE3
1 other identifier
interventional
101
1 country
1
Brief Summary
Main objective: To assess the efficacy of a phase III cardiac rehabilitation program (CRP), based on counseling in the maintenance of physical exercise (time of physical exercise per week) for patients with myocardial ischemia (MI), once the supervised physical exercise program of phase II of CRP is completed. Secondary objectives: To assess the efficacy of a phase III program of CRP based on counseling in the maintenance of physical exercise for the patient with MI in: 1) the energy expenditure per week, 2) body mass index and abdominal perimeter, 3) control of cardiovascular risk factors (smoking, high blood pressure, dyslipidemia and diabetes mellitus), 4) quality of life related to health, 5) assess the adherence to cardiac pharmacological treatment. Method: Randomized clinical trial in conglomerates, open and controlled. The intervention group will carry out phase III of CRP based on counseling in the maintenance of physical exercise. The control group will receive the usual care. The main outcome will be the physical exercise time per week after finish the supervised physical exercise program of phase II of CRP and at 6 and 12 month later according to the 7-day Physical Activity Recall.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2019
CompletedStudy Start
First participant enrolled
October 1, 2019
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2022
CompletedOctober 31, 2022
June 1, 2022
2.7 years
July 19, 2019
October 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The physical exercise minutes performed by the patient per week
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
The physical exercise minutes performed by the patient per week
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
The physical exercise minutes performed by the patient per week
The physical exercise minutes performed by the patient per week will be recorded through the 7-day Physical Activity Recall (PAR) questionnaire.
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
Secondary Outcomes (37)
The energy expenditure by the patient per week
At baseline, when the supervised physical exercise program of phase II of the CRP has been completed.
The energy expenditure by the patient per week
At 6 months of the supervised physical exercise program of phase II of the CRP has been completed.
The energy expenditure by the patient per week
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
The body mass index (BMI)
At baseline of the supervised physical exercise program of phase II of the CRP has been completed.
The body mass index (BMI)
At 12 months of the supervised physical exercise program of phase II of the CRP has been completed.
- +32 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONThe usual care in patients with myocardial ischemia without other cardiovascular risk factors (CVFR) will be to attend one visit per year with doctor and nurse of the local health center. In this visit, it will be done a blood test and an electrocardiogram. Blood pressure, weight, body mass index, abdominal circumference will be measured and, in case of detecting enolic habit, smoking or sedentary lifestyle, generic advice will be done. If the patient, apart from myocardial ischemia, presents diabetes mellitus type 2, 3-4 follow-up visits per year will be recommended and will be increased according to specific needs. In case of presenting hypertension, will be recommended 2 visits with the nurse and one visit with the doctor per year and will be increased according to specific needs. In addition, in this case the blood pressure is checked every 6 months. During all visits, professionals will reinforce the control of CVRF and the maintenance of a long-term cardio-healthy lifestyle.
Intervention group
EXPERIMENTALPatient will go to health center to visit the cardiac rehabilitation (CR) reference team, which is composed for a doctor and a nurse. This team will establish the guideline of action in the maintenance and/or increase in the physical exercise practice, in function of the resources of each zone and the preferences and motivations of the patient. They also reinforce the control of CVRF and the maintenance of a long-term cardio-healthy lifestyle. At the end of the visit, control visit will be given with the CR reference team at 3, 6 and 12 months after completing the supervised physical exercise program of phase II of the CRP. In case of detecting specific needs for the patient and/or relapses, the team will consult with the appropriate professional (cardiologist, cardiology nurse, physiotherapist, rehabilitator, nutritionist and/or psychologist). At the same time, the patient will be informed of the possibility of re-evaluating the CR reference team.
Interventions
Objectives will be established with the patient to increase the practice of physical exercise and reinforce the control of cardiovascular risk factors (CVRF) and the maintenance of a long-term cardio-healthy lifestyle.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with myocardial ischemia, angina pectoris, other specific forms of chronic ischemic heart disease or unspecified ischemic heart disease.
- Patients who have completed the supervised physical exercise program of phase II of the CRP.
- Absence of cognitive deficit (Pfeiffer test: 0-2 mistakes).
- Sufficient functional capacity to follow the CRP (Barthel index \>60)
- Residence in catchment area of Bages and Moianès.
- Providing signed informed consent.
You may not qualify if:
- Symptoms of right heart failure producing pulmonary hypertension.
- Dyspnea caused by severe pulmonary pathology.
- Additional comorbidities affecting the prognosis of cardiac disease.
- Major comorbidities or limitations that could interfere with the exercise training programme.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Núria Santaularia Capdevilalead
- Institut Català de la Salutcollaborator
Study Sites (1)
Althaia Xarxa Assistencial Universitària de Manresa
Manresa, Barcelona, 08243, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Núria Santaularia, MSc, PhD
Althaia Xarxa Assistencial Universitària de Manresa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 19, 2019
First Posted
February 5, 2020
Study Start
October 1, 2019
Primary Completion
May 30, 2022
Study Completion
May 30, 2022
Last Updated
October 31, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- When final results of the study will be published.
- Access Criteria
- Data will be shared with researchers or research team with a protocol study approved and/or with a clinical trial registred at a clinical trial register.
Data will be shared with a request of researchers. All the information will be anonymous.